Odesivimab is a ''

Zaire ebolavirus ''Orthoebolavirus zairense'' or Zaire ebolavirus, more commonly known as Ebola virus (; EBOV), is one of six known species within the genus ''Ebolavirus''. Four of the six known ebolaviruses, including EBOV, cause a severe and often fatal hem ...

'' glycoprotein-directed human monoclonal antibody that is part of the

fixed-dose combination A combination drug is a combination of two or more pharmaceutical drugs as active ingredients combined into a single dosage form, typically as a ''fixed-dose combination'', with each constituent standardized to specifications of a fixed dose. Fix ...

atoltivimab/maftivimab/odesivimab Atoltivimab/maftivimab/odesivimab, sold under the brand name INMAZEB, is a fixed-dose combination of three monoclonal antibodies for the treatment of ''Zaire ebolavirus'' (Ebola virus). It was developed by Regeneron Pharmaceuticals and contain ...

that is used for the treatment of ''Zaire ebolavirus'' (

Ebola Ebola, also known as Ebola virus disease (EVD) and Ebola hemorrhagic fever (EHF), is a viral hemorrhagic fever in humans and other primates, caused by ebolaviruses. Symptoms typically start anywhere between two days and three weeks after in ...

virus).

References

External links

* * Ebola Monoclonal antibodies {{antiinfective-drug-stub